Ifinatamab
Product Specifications
CAS Number
2484870-90-6
Target
Immunology/Inflammation related|||B7|||Integrin
Related Pathways
Immunology/Inflammation|||Cytoskeletal Signaling
Purity
0.991
Bioactivity
Ifinatamab is a humanised monoclonal immunoglobulin that targets and inhibits the B7-H3 protein. Ifinatamab can be used to synthesise the ADC drug Ifinatamab deruxtecan for the treatment of small cell lung cancer (SCLC) .
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/121304362390650916/T78292
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TRC-B185525-500MG 500 mg
1,2-Benzenedicarboxylic Acid, Mixed Decyl, Hexyl and Octyl Diesters(1:1:1 Mixture of B185420 and D228455 and D228460)
Ask
View Details 
MBS6208392-01 0.1 mL
RSU1 (Ras Suppressor Protein 1, FLJ31034, RSP-1) (MaxLight 490)
Ask
View Details 
MBS6208392-02 5x 0.1 mL
RSU1 (Ras Suppressor Protein 1, FLJ31034, RSP-1) (MaxLight 490)
Ask
View Details